Metabotropic glutamate receptor 7

Metabotropic glutamate receptor 7 is a protein that in humans is encoded by the GRM7 gene.[5][6][7]

GRM7
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesGRM7, GLUR7, GPRC1G, MGLU7, MGLUR7, PPP1R87, glutamate metabotropic receptor 7
External IDsOMIM: 604101 MGI: 1351344 HomoloGene: 20233 GeneCards: GRM7
Gene location (Human)
Chr.Chromosome 3 (human)[1]
Band3p26.1Start6,770,001 bp[1]
End7,741,533 bp[1]
RNA expression pattern
More reference expression data
Orthologs
SpeciesHumanMouse
Entrez

2917

108073

Ensembl

ENSG00000196277

ENSMUSG00000056755

UniProt

Q14831

Q68ED2

RefSeq (mRNA)

NM_000844
NM_181874
NM_181875

NM_177328
NM_001346640

RefSeq (protein)

NP_000835
NP_870989

NP_001333569
NP_796302

Location (UCSC)Chr 3: 6.77 – 7.74 MbChr 6: 110.65 – 111.57 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Function

L-glutamate is the major excitatory neurotransmitter in the central nervous system and activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors, that have been divided into 3 groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5 and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3 while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. Alternative splice variants of GRM8 have been described but their full-length nature has not been determined.[7]

Ligands

Agonists

Antagonists

  • MMPIP: allosteric antagonist/inverse agonist[11]

Negative allosteric modulator

Interactions

Metabotropic glutamate receptor 7 has been shown to interact with PICK1.[13]

Clinical

Mutations in both copies have been associated with developmental and epileptic encephalopathy, microcephaly, hypomyelination and cerebral atrophy.[14]

gollark: Also that.
gollark: ... well, you can sell related products, and everyone benefits from having a better planet.
gollark: ... selling power?
gollark: Invasion of privacy is, in fact, bad, which is why end to end encryption is so important.
gollark: Gates doesn't run Microsoft.

References

  1. GRCh38: Ensembl release 89: ENSG00000196277 - Ensembl, May 2017
  2. GRCm38: Ensembl release 89: ENSMUSG00000056755 - Ensembl, May 2017
  3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. Okamoto N, Hori S, Akazawa C, Hayashi Y, Shigemoto R, Mizuno N, Nakanishi S (February 1994). "Molecular characterization of a new metabotropic glutamate receptor mGluR7 coupled to inhibitory cyclic AMP signal transduction". J Biol Chem. 269 (2): 1231–6. PMID 8288585.
  6. Makoff A, Pilling C, Harrington K, Emson P (January 1997). "Human metabotropic glutamate receptor type 7: molecular cloning and mRNA distribution in the CNS". Brain Res Mol Brain Res. 40 (1): 165–70. doi:10.1016/0169-328X(96)00110-6. PMID 8840028.
  7. "Entrez Gene: GRM7 glutamate receptor, metabotropic 7".
  8. Li X, Gardner EL, Xi ZX (2008). "The Metabotropic Glutamate Receptor 7 (mGluR7) Allosteric Agonist AMN082 Modulates Nucleus Accumbens GABA and Glutamate, but not Dopamine, in Rats". Neuropharmacology. 54 (3): 542–51. doi:10.1016/j.neuropharm.2007.11.005. PMC 2410088. PMID 18155073.
  9. Palucha A, Klak K, Branski P, van der Putten H, Flor PJ, Pilc A (2007). "Activation of the mGlu7 receptor elicits antidepressant-like effects in mice". Psychopharmacology. 194 (4): 555–62. doi:10.1007/s00213-007-0856-2. PMID 17622518.
  10. Pelkey KA, Yuan X, Lavezzari G, Roche KW, McBain CJ (2007). "mGluR7 undergoes rapid internalization in response to activation by the allosteric agonist AMN082". Neuropharmacology. 52 (1): 108–17. doi:10.1016/j.neuropharm.2006.07.020. PMID 16914173.
  11. Suzuki G, Tsukamoto N, Fushiki H, Kawagishi A, Nakamura M, Kurihara H, Mitsuya M, Ohkubo M, Ohta H (2007). "In vitro pharmacological characterization of novel isoxazolopyridone derivatives as allosteric metabotropic glutamate receptor 7 antagonists". J. Pharmacol. Exp. Ther. 323 (1): 147–56. doi:10.1124/jpet.107.124701. PMID 17609420.
  12. Kalinichev M, Rouillier M, Girard F, et al. (2013). "ADX71743, a potent and selective negative allosteric modulator of metabotropic glutamate receptor 7: in vitro and in vivo characterization". J. Pharmacol. Exp. Ther. 344 (3): 624–36. doi:10.1124/jpet.112.200915. PMID 23257312.
  13. Dev KK, Nakajima Y, Kitano J, Braithwaite SP, Henley JM, Nakanishi S (October 2000). "PICK1 interacts with and regulates PKC phosphorylation of mGLUR7". J. Neurosci. 20 (19): 7252–7. doi:10.1523/JNEUROSCI.20-19-07252.2000. PMC 6772771. PMID 11007882.
  14. Marafi D, Mitani T, Isikay S, Hertecant J, Almannai M, Manickam K, Abou Jamra R, El-Hattab AW, Rajah J, Fatih JM, Du H, Karaca E, Bayram Y, Punetha J, Rosenfeld JA, Jhangiani SN, Boerwinkle E1, Akdemir ZC, Erdin S, Hunter JV, Gibbs RA, Pehlivan D, Posey JE, Lupski JR (2020) Biallelic GRM7 variants cause epilepsy, microcephaly, and cerebral atrophy. Ann Clin Transl Neurol

Further reading

This article incorporates text from the United States National Library of Medicine, which is in the public domain.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.